Aortic endothelium in HIV-1 infection: Chronic injury, activation, and increased leukocyte adherence

American Journal of Pathology

Volumn 149, Issue 6, 1996, Pages 1887-1898

  Zietz, Christian ^a   Hotz, Barbara ^a   Stürzl, Michael ^b   Rauch, Elisabeth ^a   Penning, Randolph ^a   Löhrs, Udo ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HLA DR ANTIGEN; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY KI 67; VASCULAR CELL ADHESION MOLECULE 1;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIGEN EXPRESSION; AORTA; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; KAPOSI SARCOMA; LEUKOCYTE ADHERENCE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VASCULAR ENDOTHELIUM;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; AORTA; AORTA, ABDOMINAL; AORTIC DISEASES; CELL ADHESION; CELL DIVISION; CHILD; E-SELECTIN; ENDOTHELIUM, VASCULAR; FEMALE; HIV-1; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; KI-67 ANTIGEN; LEUKOCYTES; MALE; MIDDLE AGED; VIRUS ACTIVATION;

EID: 0029807842     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Beilke MA: Vascular endothelium in immunology and infectious disease. Rev Infect Dis 1989, 11:273-283
2. Pober JS, Doukas J, Hughes CC, Savage CO, Munro JM, Cotran RS: The potential roles of vascular endothelium in immune reactions. Hum Immunol 1990, 28: 258-262
3. Hughes CC, Savage CO, Pober JS: The endothelial cell as a regulator of T-cell function, Immunol Rev 1990, 117:85-102
4. Rubanyi GM: The role of endothelium in cardiovascular homeostasis and diseases. J Cardiovasc Pharmacol 1993, 22:S1-S14
5. Krapf FE, Herrmann M, Leitmann W, Schwartlander B, Kalden JR: Circulating immune complexes in HIV-infected persons. Klin Wochenschr 1990, 68:299-305
6. Scott Algara D, Vuillier F, Marasescu M, de Saint Martin J, Dighiero G: Serum levels of IL-2, IL-1α, TNF-α, and soluble receptor of IL-2 in HIV-1-infected patients. AIDS Res Hum Retroviruses 1991, 7:381-386
7. Sinicco A, Biglino A, Sciandra M, Forno B, Pollono AM, Raiteri R, Gioannini P: Cytokine network and acute primary HIV-1 infection. AIDS 1993, 7:1167-1172
8. Hofman FM, Wright AD, Dohadwala MM, Wong Staal F, Walker SM: Exogenous tat protein activates human endothelial cells. Blood 1993, 82:2774-2780
9. Holland GN, Gottlieb MS, Yee RD, Schanker HM, Pettit TH: Ocular disorders associated with a new severe acquired cellular immunodeficiency syndrome. Am J Ophthalmol 1982, 93:393-402
10. Holland GN, Pepose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY: Acquired immune deficiency syndrome: ocular manifestations. Ophthalmology 1983, 90:859-873
11. Pepose JS, Holland GN, Nestor MS, Cochran AJ, Foos RY: Acquired immune deficiency syndrome: pathogenic mechanisms of ocular disease. Ophthalmology 1985, 92:472-484
12. Freeman WR, Chen A, Henderly DE, Levine AM, Luttrull JK, Urrea PT, Arthur J, Rasheed S, Cohen JL, Neuberg D, Leung RJ: Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol 1989, 107:229-235
13. Engstrom RE Jr, Holland GN, Hardy WD, Meiselman HJ: Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol 1990, 109:153-161
14. Turu AC, Civera AA, Latorre X: Ophthalmic manifestations of acquired immunodeficiency syndrome: a study of thirty-four patients. Ophthalmologica 1988, 197:113-119
15. Tatsch K, Schielke E, Bauer WM, Markl A, Einhäupl KM, Kirsch CM: Functional and morphological findings in early and advanced stages of HIV infection: a comparison of 99mTc-HMPAO SPECT with CT and MRI studies. Nuklearmedizin 1990, 29:252-258
16. Schielke E, Tatsch K, Pfister HW. Trenkwalder C, Leinsinger G, Kirsch CM, Matuschke A, Einhäupl KM: Reduced cerebral blood flow in early stages of human immunodeficiency virus infection. Arch Neurol 1990, 47:1342-1345
17. Joshi VV, Pawel B, Connor E, Sharer L, Oleske JM, Morrison S, Marin Garcia J: Arteriopathy in children with acquired immune deficiency syndrome. Pediatr Pathol 1987, 7:261-275
18. Schved JF, Gris JC, Arnaud A, Martinez P, Sanchez N, Wautier JL, Sarlat C: von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator. J Lab Clin Med 1992, 120:411-419
19. Drouet L, Scrobohaci ML, Janier M, Baudin B: Endothelial cells: target for the HIV1 virus? Nouv Rev Fr Hematol 1990, 32:103-106
20. Lafeuillade A, Alessi MC, Poizot Martin I, Boyer Neumann C, Zandotti C, Quilichini R, Aubert L, Tamalet C, Juhan Vague I, Gastaut JA: Endothelial cell dysfunction in HIV infection. J Acquired Immune Defic Syndr 1992, 5:127-131
21. Janier M, Flageul B, Drouet L, Scrobohaci ML, Villette JM, Palangie A, Cottenot F: Cutaneous and plasma values of von Willebrand factor in AIDS: a marker of endothelial stimulation? J Invest Dermatol 1988, 90: 703-707
22. Rolinski B, Geier SA, Sadri I, Klauss V, Bogner JR, Ehrenreich H, Goebel FD: Endothelin-1 immunoreactivity in plasma is elevated in HIV-infected patients with retinal microangiopathic syndrome. Clin Investig 1994, 72:288-293
23. Centers for Disease Control: 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992, 41:1-19
24. Freudenberg N, Riese K-H, Freudenberg MA: The Vascular Endothelial System. Stuttgart, Gustav Fischer Verlag, 1983, pp 1-114
25. Riese KH, Freudenberg N, Haas W: En face preparation methods for investigation of endothelial and mesothelia. Pathol Res Pract 1978, 162:327-336
26. Gomori G: Chloracylesters as histochemical substrates. J Histochem Cytochem 1953, 1:469-470
27. Hsu SM, Raine L, Fanger H: The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase techniques. Am J Clin Pathol 1981, 75:816-821
28. Cordell JL, Falini B, Erber WN. Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KA, Stein H, Mason DY: Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984, 32:219-229
29. Remmele W, Hildebrand U, Hienz HA, Klein PJ, Vierbuchen M, Behnken LJ, Heicke B, Scheldt E: Comparative histological, histochemical, immunohistochemical, and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 1986, 409:127-147
30. Page C, Rose M, Yacoub M, Pigott R: Antigenic heterogeneity of vascular endothelium. Am J Pathol 1992, 141:673-683
31. Poole JCF, Sanders AG, Florey HW: The regeneration of aortic endothelium. J Pathol Bacteriol 1958, 75:133-143
32. Cotton RE, Harwood TR, Wartman WB: Regeneration of aortic endothelium. J Pathol Bacteriol 1961, 81:175-180
33. Lindner V, Collins T: Expression of NF-κB and IκB-a by aortic endothelium in an arterial injury model. Am J Pathol 1996, 148:427-438
34. Sonigo P, Courgnaud V, Castelot S, Fossati B, Lemeignan B, Leste-Lasserre T, Nerrienet E, Valere T, Pancino G: Evolution of the viral burden: a consequence of the adaptive strategies of persistent lentiviruses? Viral Quantification in HIV Infection. Edited by JM Andrieu. Paris, John Libbey Eurotext, 1991, pp 113-118
35. Ward JM, O'Leary TJ, Baskin GB, Benveniste R, Harris CA, Nara PL, Rhodes RH: Immunohistochemical localization of human and simian immunodeficiency viral antigens in fixed tissue sections. Am J Pathol 1987, 127:199-205
36. Rhodes RH, Ward JM: Immunohistochemistry of human immunodeficiency virus in the central nervous system and an hypothesis concerning the pathogenesis of AIDS meningoencephalomyelitis. Prog AIDS Pathol 1989, 1:167-179
37. Pober JS: Warner-Lambert/Parke-Davis award lecture: Cytokine-mediated activation of vascular endothelium. Am J Pathol 1988, 133:426-433
38. Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA: Interleukin-1 activation of vascular endothelium: effects on procoagulant activity and leukocyte adhesion. Am J Pathol 1985, 121:394-403
39. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Physiol Rev 1990, 70:427-451
40. Pober JS, Collins T, Gimbrone MA Jr, Libby P, Reiss CS: Inducible expression of class II major histocornpatibility complex antigens and the immunogenicity of vascular endothelium. Transplantation 1986, 41:141-146
41. Collins T, Korman AJ, Wake CT, Boss JM, Kappes DJ, Fiers W, Ault KA, Gimbrone MA Jr, Strominger JL, Pober JS: Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci USA 1984, 81:4917-4921
42. Fuchs D, Hausen A, Reibnegger G, Werner ER, Werner Felmayer G, Dierich MP, Wachter H: Interferon-γ concentrations are increased in sera from individuals infected with human immunodeficiency virus type 1. J Acquired Immune Defic Syndr 1989, 2:158-162
43. Marschang P, Gürtler L, Totsch M, Thielens NM, Arlaud GJ, Hittmair A, Katinger H, Dierich MP: HIV-1 and HIV-2 isolates differ in their ability to activate the complement system on the surface of infected cells. AIDS 1993, 7:903-910
44. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR: Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 1992, 74: 1045-1052
45. Gariano RF, Rickman LS, Freeman WR: Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome. West J Med 1993, 158:254-262
46. Zietz C, Speiser B, Rauch E, Löhrs U: Untersuchungen an Endothel und Gefässsystem bei HIV-Infektion. Verh Dtsch Ges Pathol 1992, 76:541
47. Rhodes RH: Evidence of serum-protein leakage across the blood-brain barrier in the acquired immunodeficiency syndrome. J Neuropathol Exp Neurol 1991, 50: 171-183
48. Petite CK, Cash KS: Blood-brain barrier abnormalities in the acquired immunodeficiency syndrome: immunohistochemical localization of serum proteins in postmortem brain. Ann Neurol 1992, 32:658-666
49. Fries JW, Williams AJ, Atkins RC, Newman W, Lipscomb MF, Collins T: Expression of VCAM-1 and E-selectin in an in vivo model of endothelial activation. Am J Pathol 1993, 143:725-737
50. Stürzl M, Brandstetter H, Roth WK: Kaposi's sarcoma: a review of gene expression and ultrastructure of KS spindle cells in vivo. AIDS Res Hum Retroviruses 1992, 8:1753-1763
51. Stürzl M, Roth WK, Brockmeyer NH, Zietz C, Speiser B, Hofschneider PH: Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 1992, 89:7046-7050
52. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B: Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995, 92:4838-4842
53. Stürzl M, Brandstetter H, Zietz C, Eisenburg B, Raivich G, Gearing DP, Brockmeyer NH: Identification of interleukin-1 and platelet-derived growth factor-B as major mitogens for spindle cells of Kaposi's sarcoma: a combined in vitro and in vivo analysis. Oncogene 1995, 10:2007-2016
54. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS: Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869
55. Pober JS, Cotran RS: Immunologic interactions of T lymphocytes with vascular endothelium. Adv Immunol 1991, 50:261-302
56. Guinan EC, Smith BR, Doukas JT, Miller RA, Pober JS: Vascular endothelial cells enhance T cell responses by markedly augmenting IL-2 concentrations. Cell Immunol 1989, 118:166-177
57. Teitel JM, Shore A, Read SE, Schiavone A: Immune function of vascular endothelial cells is impaired by HIV. J Infect Dis 1989, 160:551-552
58. Murray HW, Weite K, Jacobs JL, Rubin BY, Mertelsmann R, Roberts RB: Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J Clin Invest 1985, 76:1959-1964